Daily Stereotactic Ultrasound Prostate Targeting: Inter-user Variability
Open Access
- 1 April 2003
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 2 (2) , 161-169
- https://doi.org/10.1177/153303460300200213
Abstract
We analyzed the inter-user variability of patient setup for prostate radiotherapy using a stereotactic ultrasound-targeting device. Setup variations in 20 prostate cancer patients were analyzed. Users were a radiation oncologist, a medical physicist, four radiation technologists (RTT) and a radiologist. The radiation oncologist, radiologist, physicist and two RTTs were experienced users of the system (>18 months of experience); two RTTs were users new to the system. Gold standard for this analysis was a control CT acquired immediately following ultrasound targeting. For inter-user variability assessments, the radiation oncologist provided a set of axial and sagittal freeze-frames (standard freeze-frames) for virtual targeting by all users. Additionally each user acquired individual freeze-frames for target alignments. We analyzed the range of virtual setups in each patient along the principal room axes based on standard and individual freeze-frames. The magnitude of residual setup error and percentage of setup change for each user was assessed by control CT/planning CT comparison with individual virtual shifts. A total of 184 alignments were analyzed. The range of virtual shifts between users was 2.7±1.4, 3.6±1.1, and 4.4±1.4 mm (mean±SD) in x, y and z-direction for setups based on standard freeze-frames and 3.9±2.6, 6.0±4.7, and 5.4±2.7 mm for setups based on individual freeze-frames. When only virtual shifts of experienced users were analyzed, the mean ranges were reduced by up to 2.4 mm. Average magnitude of initial setup error before ultrasound targeting was 14.3 mm. Average improvement of prostate setup was 63.1±23.4% in experienced and 35.14±37.7% in inexperienced users, respectively (p<0.0001). Only 5 of 184 (2.7%) virtual alignments would have introduced new larger setup errors (mean 3.2 mm, range 0.2 to 9.5 mm) than the magnitude of the initial setup error. We conclude that ultrasound guided treatment setup for patients treated for prostate cancer can be performed with high inter-user consistency and does lead to improved treatment setup in more than 97% of attempted setups. Experienced use is correlated with a reduced range of setups between users and higher degree of setup improvement when compared with users new to the system.Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of an ultrasoundguided prostate positioning system using implanted gold markersInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Evaluation of the use of the bat ultrasound system for prostate localization and repositioning: an inter-user studyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Set-up verification using portal images of implanted prostate markers: an inter-observer studyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Inter-observer variation in prostate localization utilizing BATInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Commissioning and quality assurance of an optically guided three-dimensional ultrasound target localization system for radiotherapyMedical Physics, 2002
- The talon removable head frame system for stereotactic radiosurgery/radiotherapy: measurement of the repositioning accuracyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation studyInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Late GI and GU complications in the treatment of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effectInternational Journal of Radiation Oncology*Biology*Physics, 1996